Bavarian Nordic partners with Serum Institute for Mpox vaccine production

Q: How long will it take to read this news story?

The story "Bavarian Nordic partners with Serum Institute for Mpox vaccine production" has 486 words across 22 sentences, which will take approximately 3 - 5 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Bavarian Nordic partners with Serum Institute for Mpox vaccine production" was covered 5 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 245 news stories per day. It's most recent story was published 2 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #24428852</li><li>URL: https://beamstart.com/news/bavarian-nordic-partners-with-serum-17343395003013</li></ul>

Business Standard Logo Business Standard 5h ago

Bavarian Nordic partners with Serum Institute for Mpox vaccine production - Business Standard

Quick Summary:

International health authorities have mobilised resources to combat the outbreak, emphasising the need for vaccination campaigns and enhanced surveillance.

We continue to work with partners globally to explore additional opportunities for local manufacturing to further support vaccine supply.

So far in 2024, over 65,700 cases of Mpox have been recorded, mainly in the Democratic Republic of Congo, with approximately 1,200 fatalities.